GPT and type 2 diabetes mellitus: Simple scoring systems indirectly measure fibrogenesis and are derived from clinical risk factors of fibrosis progression (e.g. obesity, T2DM) and routinely available biochemistry reflecting liver dysfunction (AST, ALT, platelet count, albumin, etc).